Skip to main content
Signal8

SELICK HAROLD E

SEC insider (Form 3/4/5 filer). CIK 0001287233. Director at Protagonist Therapeutics, Inc (PTGX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 26, 2026. Located in NEWARK, CA.

Companies SELICK HAROLD E has filed insider reports for

  • Protagonist Therapeutics, Inc (PTGX): Director
  • Molecular Templates, Inc. (MTEM): Director
SELICK HAROLD E profile photo

SELICK HAROLD E

CIK: 0001287233

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Protagonist Therapeutics, Inc logo
PTGX

Protagonist Therapeutics, Inc

Director
Molecular Templates, Inc. logo
MTEM

Molecular Templates, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Mar 26, 2026
    Exercise
    Direct
    24K shares at avg. $12.88$309K
  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Mar 26, 2026
    Sale
    Direct
    24K shares at avg. $105.00$2.5M
  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Jan 9, 2026
    Exercise
    Direct
    14.3K shares at avg. $4.21$60K
  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Jan 2, 2026
    Award
    Direct
    2.7K shares-
  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Apr 28, 2025
    Exercise
    Direct
    10.7K shares at avg. $1.16$12K
  • Protagonist Therapeutics, Inc logo
    PTGX

    Protagonist Therapeutics, Inc

    Jan 2, 2025
    Award
    Direct
    5.1K shares-
  • Molecular Templates, Inc. logo
    MTEM

    Molecular Templates, Inc.

    Sep 27, 2024
    Award

    Stock Option (right to buy)

    Direct
    1K shares-

1-7 of 7